|
Arrest That Governor!
At last week's debate, President
Bush was asked why he had blocked imports of
inexpensive drugs from Canada. "I haven't yet," he
responded, adding, "It may very well be here in
December you hear me say I think there's a safe way"
to import drugs. In the 2000 campaign, Bush was even
more unequivocal. Drug importation, he said, "makes
sense."
First, "I haven't yet" amounts to a bald lie. If
his administration does not allow it, he's blocking
it. Second, why wait until December to change his
policy? And if the idea still "makes sense," why is
his administration four years later trying to rub
out any organized importation?
The Food and Drug Administration has been sending
bullying letters to governors whose states try to
establish safe ways of importing drugs from
established pharmacies. The most recent such letter,
sent to Illinois Gov. Rod Blagojevich, called his
state's newly launched I-SaveRx program "illegal."
If Bush actually believes that, let's see him put
Blagojevich in handcuffs and have the governor do
the perp walk into federal court.
Bush aides, meanwhile, are leaning on Senate
Majority Leader Bill Frist (R-Tenn.) to block a
Senate vote on a bill by Sens. Olympia J. Snowe
(R-Maine) and Byron L. Dorgan (D-N.D.) that would
lift the outrageous restrictions that prevent U.S.
consumers from buying drugs from abroad, where
prices are controlled and often 40% to 60% lower
than in the United States.
Frist and FDA officials say the risks of such
reshipping far outweigh the benefits. But it's more
than a stretch to argue that the medications Snowe
and Dorgan would let U.S. patients purchase --
FDA-approved and shipped back to the United States
in their original packages -- are somehow more
dangerous than medications such as vaccines, which
frequently are manufactured abroad and shipped
straight to U.S. doctors' offices.
Pharmaceutical concerns have long made a second
argument against drug re-importation: It would
eviscerate the profit margins they need to produce
new drugs. But there's no reason why Americans
should have to shoulder the burden so
disproportionately, especially because drug makers
spend more on marketing and lobbying than research
and still make record profits.
Because the House passed a similar bill last year
by a surprisingly strong 243-186 vote, Senate
approval could compel legislators to send the
Snowe-Dorgan bill to the president's desk as early
as December. Whether Bush wins or loses, that would
be an ideal way to find out if he meant what he
said.
To Take Action: Call Sen. Frist at (202)
224-3344. |